3Fazlinezhad A, Rezaeian MK, Yousefzadeh H, et al. Plas ma brain natriuretic peptide(BNP) as an indicator of left ventricular function, early outcome and mechanical com- plications after acute myocardial infarction[J]. Clin Med Insights Cardiol, 2011,5 : 77-83.
4Manola S,Pavlovic N,Radebic V,et al. Btype natriuretic peptide as predictor of heart failure in patients with acute ST elevation myocardial infarction, single-vessel disease, and complete revascularization: follow-up study[J]. Croat Med J,2009,50(5) :449-454.
5Eggers KM, Lagerqvist B, Venge P, et al. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome[J]. J Am Coll Cardiol,2009,54 (4) :357-364.
6Leon de la Fuente R,Naesgaard PA, Nilsen ST, et al. B type natriuretic peptide and high sensitive C-reactive pro- tein predict 2 year all cause mortality in chest pain pa- tients: a prospective observational study from Salta, Ar- gentina[J]. BMC Cardiovasc Disord, 2011,11 : 57.
7Alpert JS, Thygesen K, Antman E, et al. Myocardial in- farction redefined-a consensus document of The Joint Eu ropean Society of Cardiology/American College of Cardi- ology Committee for the redefinition of myocardial infarc- tion[J].J Am Coll Cardiol,2000,36(3):959 969.
8Hall TS, H allen J, Agewall S, et al. Changes in diagnosing non-ST-segment elevation myocardial infarction after the introduction of a new high-sensitivity cardiac troponin T assay : a single centre experience[J]. Clin Lab, 2012,58 ( 9/ 10) : 1029-1036.
9Perna ER, Aspromonte N, Cimbaro Canella JP, et al. Mi nor myocardial damage is a prevalent condition in patients with acute heart failure syndromes and preserved systolic function with long-term prognostic implications. A report from the CIAST-HF (Collaborative halo-Argentinean Study on cardiac troponin T in heart failure) study[J]. J Card Fail,2012,18(11) :822-830.
10De Lemos JA, Morrow DA, Bentley JH, et al. The prog nostic value of B-type natriuretic peptide in patients with acute coronary syndromes[J]. N Engl J Med, 2001, 345 (14):1014-1021.
7Reinstadler S J, Klug G, Feistritzer H J, et al. Copeptin Testing in Acute Myocardial Infarction: Ready for Routine Use[J]. Disease markers, 2015(61): 1-9.
8Lipinski M J, Escrrcega R O, D'Ascenzo F, et al. A systematic re- view and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction [J]. The American journal of cardiology, 2014,113(9): 1581-1591.
9Holwerda D A. A glycopeptide from the posterior lobe of pig pitu- itaries. I. Isolation and characterization [J]. European Journal of Biochemistry / FEBS, 1972, 28(3): 334-339.
10Bolignano D, Cabassi A, Fiaccadori E, et al. Copeptin (ctproavp), a new tool for understanding the role of vasopressin in pathophysiolo- gy[J]. Clinical chemistry and laboratory medicine: CCLM/ FES- CC, 2014, 52(10): 1447-1456.
